Precision Medicine

Precision Medicine vertical includes products and services that leverage the science of genomics, proteomics, pharmacogenomics, diagnostic technologies, and information technologies and capitalize on the trends toward disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle.

To Know more about Precision Medicine Practice Contact Us Or email us [email protected]

Global Hematologic Malignancies Testing Market: Focus on Product, Disease, Technology, End User, Region/Country Data and Competitive Landscape – Analysis and Forecast, 2018-2025

The hematologic malignancies testing industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.24% during the forecast period, 2019-2025.

Request Sample

Global Molecular Forensics Market: Focus on Product, Technology Application, End User, Country Data (16 Countries), and Competitive Landscape – Analysis and Forecast, 2019-2029

The molecular forensics industry analysis by BIS Research projects the market to grow at a significant CAGR of 9.09% during the forecast period, 2019-2029. The molecular forensics market generated $996.9 million revenue in 2018, in terms of value.

Request Sample

Global Human Microbiome Therapeutics Market: Focus on Drugs, Pipeline Analysis, Funding Scenario, Therapeutic Application, 10 Countries Data, and Competitive Landscape – Analysis and Forecast, 2019-2029

Human Microbiome Therapeutics Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 33.00% during the forecast period 2019-2029.

Request Sample

Global NGS Sample Preparation Market: Focus on Product (Workstation (Open System, Closed System), Standalone, Consumables), Workflow (Fragmentation, Quality Control), Therapy Area (Oncology, Neonatal), Application (DNA Sequencing, Metagenomics), End User - Forecast to 2025

The NGS sample preparation industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.54% during the forecast period, 2019-2025.

Request Sample

Global Blockchain in Genomics Market: Focus on Business Models, Services, Applications, End Users, 11 Countries Data, and Competitive Landscape – Analysis and Forecast, 2019-2029

The global blockchain in genomic market analysis by BIS Research projects the market to grow at a significant CAGR of 66.42% during the forecast period, 2019-2029.

Request Sample

Global Molecular Diagnostics Point of Care Market: Focus on Application, Technology, Type, End User, Country Data (15 Countries), and Competitive Landscape – Analysis and Forecast, 2019-2029

The global molecular diagnostic point of care industry analysis by BIS Research projects the market to grow at a significant CAGR of 12.14% during the forecast period, 2019-2029.

Request Sample

Global NGS-Based Monitoring and Diagnostic Test Market: Focus on Application, Method, Type, End User, Country Data (17 Countries), and Competitive Landscape – Analysis and Forecast, 2019-2028

The NGS based monitoring and diagnostic test Industry analysis by BIS Research projects the market to grow at a significant CAGR of 18.08% during the forecast period, 2019-2028. The NGS based monitoring and diagnostic test market generated $3,354.8 million revenue in 2018, in terms of value.

Request Sample

Population Genomics: National Strategy and Implementation

The aim of the population genomic initiatives implemented across the globe is to develop the biobank of genomic datasets facilitating the understanding of interaction between the gene and the phenotypic expression.

Request Sample

China Precision Medicine Market: Focus on Ecosystems, Applications, and Competitive Landscape – Analysis and Forecast, 2019-2029

The China Precision Medicine Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 12.82% during the forecast period, 2019-2029.

Request Sample

Global Oligonucleotide Synthesis Market: Focus on Products, Applications, End Users, Region/Country Data (17 Region/Countries), and Competitive Landscape – Analysis and Forecast, 2019-2029

The Global Oligonucleotide Synthesis Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 11.02% during the forecast period from 2019 to 2029.

Request Sample

Global Single Cell Multi-Omics Market: Focus on Global Single Cell Multi-Omics Market by Product, Type, Workflow, End-User 15 Countries Mapping, and Competitive Landscape - Analysis and Forecast, 2019-2025

The global single cell multi-omics industry analysis by BIS Research projects that the market was valued at $1.83 billion in 2018 and is anticipated to generate a value of $5.32 billion by 2025.

Request Sample

Global Pharmacogenomics Market: Focus on Services, Applications, Technologies, End Users, Country Data (16 Countries), and Competitive Landscape – Analysis and Forecast, 2019-2028

The global pharmacogenomics market has been witnessing a steady growth since the end of the Human Genome Project in 2003. The market is expected to continue to grow with a double digit CAGR of 6.98% during the forecast period, 2019-2028.

Request Sample

Global Direct-to-Consumer Genetic Testing (DTC-GT) Market: Focus on Direct-to-Consumer Genetic Testing Market by Product Type, Distribution Channel, 15 Countries Mapping, and Competitive Landscape - Analysis and Forecast, 2019-2028

The global direct-to-consumer market was valued at approximately $824.1 million in 2018 and is anticipated to reach $6,364.5 million by 2028.

Request Sample

Latin America Liquid Biopsy Market : Focus on Products and Services, Therapeutic Applications, Clinical Applications, Circulating Biomarkers, 5 Countries Data, Industry Insights, and Competitive Landscape – Analysis and Forecast, 2019-2025

The Latin America liquid biopsy market is anticipated to reach $70.9 million by 2025, witnessing a CAGR of 10.29% in the forecast period 2019-2025.

Request Sample

Global Cancer Immunotherapy Market: Focus on Pharmaceutical Products, Therapeutic Indication, Competitive Landscape and Region - Analysis and Forecast, 2018-2028

The global cancer immunotherapy market was valued at $39.86 billion in 2017 and is anticipated to reach $170.70 billion by 2028.

Request Sample

Global Precision Medicine Market: Focus on Precision Medicine Ecosystem, Applications, 13 Countries Mapping, and Competitive Landscape - Analysis and Forecast, 2018-2028

The global precision medicine market is anticipated to reach $216.75 billion by 2028, witnessing a CAGR of 10.64% in the forecast period 2018-2028.

Request Sample

Global Molecular Diagnostics Market: Focus on Product Type (Kits and Consumables, Systems, Software & Others), Applications, Technologies, End-User, Country Data (15 Countries), and Competitive Landscape, Analysis and Forecast, 2018-2028

The global molecular diagnostics market has been witnessing a steady growth since the end of the Human Genome Project in 2003. The market is expected to continue to grow with a double digit CAGR of 10.89% during the forecast period, 2018-2028.

Request Sample

Global Non-Invasive Prenatal Testing (NIPT) Market: Focus on Tests, Methods, Platforms, Applications, 26 Countries’ Analysis, Patent Landscape, and Competitive Landscape - Analysis and Forecast, 2018-2028

The global NIPT market is expected to reach $5.67 billion with 7,591,792 units by 2028.

Request Sample

Global Liquid Biopsy Market: Focus on Products and Services, Therapeutic Applications, Clinical Applications, Circulating Biomarkers, Country Analysis (16 Countries), Industry Insights, and Competitive Landscape - Analysis and Forecast, 2018-2028

The global liquid biopsy market is anticipated to reach $2.94 billion by 2028, witnessing a CAGR of 14.45% in the forecast period 2018-2028.

Request Sample

Global Companion Diagnostics (CDx) Market: Focus on Technology, Indication, Country-wise Analysis, Regulatory Framework, and Competitive Landscape - Analysis and Forecast, 2018-2025

The global companion diagnostics market is expected to reach $4.1 billion by 2025. With increasing demand for NGS-based companion diagnostics, the global CDx market is expected to witness double digit growth rate during the forecast period 2018-2025.

Request Sample

Strategic Evaluation of Precision Medicine: Country Analysis for Emerging Opportunities

In 2017, the global precision medicine market accounted for $48.9 billion, which is expected to reach ~$70 billion by 2020 with effective implementation of several novel technologies.

Request Sample

Global Metastatic Cancer Treatment Market : Focus on Drugs, Competitive Landscape, and Country - Analysis and Forecast (2018-2025)

The global metastatic cancer treatment market was valued $54.11 billion in 2017, and is anticipated to reach $98.24 billion by 2025.

Request Sample

Global Cell Free DNA Isolation and Extraction Market : Focus on 25 country Analysis, Competitive Landscape, Applications (NIPT, Oncology, etc.), Product and Platform- Analysis and Forecast 2018-2026

The global cell free DNA isolation and extraction market is anticipated to grow over $442.8 Million with 14,638.3 Thousand units by 2026, aided by the rising demand for non-invasive prenatal testing among high risk pregnant women and increased demand for liquid biopsy.

Request Sample

Global CRISPR Technology Market : Focus on Product, Applications, Geographical Analysis, Industry Insights And Competitive Landscape - Analysis And Forecast (2018-2027)

Genetic diseases have been responsible for approximately 25% of the global economic burden for diseases. The advent of CRISPR technology has transformed the field of genome editing and paved pathways for development of several gene therapies for the treatment of various genetic diseases. The global CRISPR technology market is expected to reach $10.55 billion by 2027.

Request Sample

Global Precision Medicine Market –Analysis and Forecast (2017-2026) (Focus on Ecosystem Player, Technology, Therapeutic Applications, Patent Landscape, Country Analysis, R&D Pipeline, Product Mapping, Market Share Analysis and Competitive Insights)

The global precision medicine market was dominated by the oncology segment in 2016. The oncology market is expected to grow with a CAGR of 10.4% from 2017 to 2026. The rise in the number of cancer cases has significantly increased the global economic burden and is estimated to be approximately $4 trillion in 2025.

Request Sample

Global Next Generation Sequencing (NGS) Market - Analysis and Forecast (2017-2024) (Focus on Product Type, Technology, Application, Country Analysis, Market Share Analysis, Funding Scenario, Trend Analysis, and Competitive Landscape)

The global next generation market was estimated at $4.14 billion in 2016 and is estimated to grow over $11.92 billion by 2024. The global next generation sequencing market is expected to grow with a double digit compound annual growth rate between the years 2017 and 2024.

Request Sample

Global Liquid Biopsy Market, Analysis and Forecast, 2017-2025 (Focus on Product Type, Therapeutic Application, End User, Market Share Analysis, Country Analysis, and Competitive Landscape)

The global liquid biopsy market is anticipated to grow over $4,434 million by 2025. With the growing prominence for non-invasive diagnostic procedures, the global liquid biopsy market is expected to register an impressive double digit growth rate in the forecast period 2016-2025.

Request Sample

Global Non-Invasive Prenatal Testing (NIPT) Market -Analysis and Forecast (2017-2023)

North America was the largest market for NIPT in 2016 in terms of revenue and volume. The region is expected to retain its leadership position throughout the forecast period as major players in the NIPT market are based in the U.S. (the largest shareholder in North America).

Request Sample

Global Pharmacogenomics (PGx) Market Analysis: Focus On Ecosystem Players (Diagnostic Test, Pharmaceutical & Others), Therapeutic Applications (Oncology, Cardiovascular & Others), and Geography– Estimation & Forecast 2022

Advancement and innovation of new healthcare technologies such as next generation sequencing, high throughput screening (HTS), and Digital PCR are developing the platform for the growth of Pharmacogenomics (PGx) market. The global PGx market is expected to grow over $14.85 billion by 2022.

Request Sample

Global Precision Medicine Market - Estimation and Forecast (2015-2022)

Precision medicine is becoming one of the most modernized trends in the healthcare industry showing an incredible growth in the recent years. According to the report put forward by the market research experts of BIS Research, the global precision medicine market is expected to grow over $88 billion by 2022 at an estimated CAGR of 12.60% from 2015 to 2022.

Request Sample

Product is added to your Wishlist

NEWSLETTER SIGNUP

Upcoming Events

Strategize Investments in EV Business: Transform your Risks into Rewards

https://biswebinar.eventbrite.com/ When: 26 Nov - 26 Nov, 2019
Where: Fremont, California, USA
Representative- BIS Research
Type of Engagement- Webcast

India Off-Highway Vehicle Summit

http://www.fiveoit.com/iohv2019/ When: 27 Nov - 28 Nov, 2019
Where: Prabhag 36, Pune, India
Representative- Mr. Paarijaat Sharma (Principal Analyst, Team
Type of Engagement- Speaker

Amsterdam Drone Week & UAM Summit 2019

https://www.amsterdamdroneweek.com/ When: 04 Dec - 06 Dec, 2019
Where: RAI Amsterdam, Europaplein 24, Amsterdam, Net
Representative- BIS Research
Type of Engagement- Knowledge Partner

CVF Off Highway

https://cvforum.in/offhighway/ When: 23 Jan - 23 Jan, 2020
Where: The Leela Ambience, Gurugram, India
Representative- Mr. Ravi Kumar Baid (Director, COO)
Type of Engagement- Speaker

Precision Medicine

Top Market Research Reports:

The hematologic malignancies testing industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.24% during the forecast period, 2019-2025.

The molecular forensics industry analysis by BIS Research projects the market to grow at a significant CAGR of 9.09% during the forecast period, 2019-2029. The molecular forensics market generated $996.9 million revenue in 2018, in terms of value.

Human Microbiome Therapeutics Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 33.00% during the forecast period 2019-2029.

The NGS sample preparation industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.54% during the forecast period, 2019-2025.

The global blockchain in genomic market analysis by BIS Research projects the market to grow at a significant CAGR of 66.42% during the forecast period, 2019-2029.

The global molecular diagnostic point of care industry analysis by BIS Research projects the market to grow at a significant CAGR of 12.14% during the forecast period, 2019-2029.

The NGS based monitoring and diagnostic test Industry analysis by BIS Research projects the market to grow at a significant CAGR of 18.08% during the forecast period, 2019-2028. The NGS based monitoring and diagnostic test market generated $3,354.8 million revenue in 2018, in terms of value.

The aim of the population genomic initiatives implemented across the globe is to develop the biobank of genomic datasets facilitating the understanding of interaction between the gene and the phenotypic expression.

The China Precision Medicine Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 12.82% during the forecast period, 2019-2029.

The Global Oligonucleotide Synthesis Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 11.02% during the forecast period from 2019 to 2029.

The global single cell multi-omics industry analysis by BIS Research projects that the market was valued at $1.83 billion in 2018 and is anticipated to generate a value of $5.32 billion by 2025.

The global pharmacogenomics market has been witnessing a steady growth since the end of the Human Genome Project in 2003. The market is expected to continue to grow with a double digit CAGR of 6.98% during the forecast period, 2019-2028.

The global direct-to-consumer market was valued at approximately $824.1 million in 2018 and is anticipated to reach $6,364.5 million by 2028.

The Latin America liquid biopsy market is anticipated to reach $70.9 million by 2025, witnessing a CAGR of 10.29% in the forecast period 2019-2025.

The global cancer immunotherapy market was valued at $39.86 billion in 2017 and is anticipated to reach $170.70 billion by 2028.

The global precision medicine market is anticipated to reach $216.75 billion by 2028, witnessing a CAGR of 10.64% in the forecast period 2018-2028.

The global molecular diagnostics market has been witnessing a steady growth since the end of the Human Genome Project in 2003. The market is expected to continue to grow with a double digit CAGR of 10.89% during the forecast period, 2018-2028.

The global NIPT market is expected to reach $5.67 billion with 7,591,792 units by 2028.

The global liquid biopsy market is anticipated to reach $2.94 billion by 2028, witnessing a CAGR of 14.45% in the forecast period 2018-2028.

The global companion diagnostics market is expected to reach $4.1 billion by 2025. With increasing demand for NGS-based companion diagnostics, the global CDx market is expected to witness double digit growth rate during the forecast period 2018-2025.

In 2017, the global precision medicine market accounted for $48.9 billion, which is expected to reach ~$70 billion by 2020 with effective implementation of several novel technologies.

The global metastatic cancer treatment market was valued $54.11 billion in 2017, and is anticipated to reach $98.24 billion by 2025.

The global cell free DNA isolation and extraction market is anticipated to grow over $442.8 Million with 14,638.3 Thousand units by 2026, aided by the rising demand for non-invasive prenatal testing among high risk pregnant women and increased demand for liquid biopsy.

The global next generation market was estimated at $4.14 billion in 2016 and is estimated to grow over $11.92 billion by 2024. The global next generation sequencing market is expected to grow with a double digit compound annual growth rate between the years 2017 and 2024.

The global liquid biopsy market is anticipated to grow over $4,434 million by 2025. With the growing prominence for non-invasive diagnostic procedures, the global liquid biopsy market is expected to register an impressive double digit growth rate in the forecast period 2016-2025.

North America was the largest market for NIPT in 2016 in terms of revenue and volume. The region is expected to retain its leadership position throughout the forecast period as major players in the NIPT market are based in the U.S. (the largest shareholder in North America).

Advancement and innovation of new healthcare technologies such as next generation sequencing, high throughput screening (HTS), and Digital PCR are developing the platform for the growth of Pharmacogenomics (PGx) market. The global PGx market is expected to grow over $14.85 billion by 2022.

NEWSLETTER SIGNUP

Categories

Upcoming Events

Strategize Investments in EV Business: Transform your Risks into Rewards

India Off-Highway Vehicle Summit

Amsterdam Drone Week & UAM Summit 2019

CVF Off Highway

Twitter Feeds

Get yourself updated on key emerging technology markets